
Chemical Name : CAY10505
CAS : 1218777-13-9
Synonyms: (5E)-5-{[5-(4-Fluorophenyl)-2-furyl]methylene}-1,3-thiazolidine-2,4-dione
Storage:at -20℃ 2 years
Biologieal
CAY10505 is a potent PI3Kγ inhibitor with an IC50 of 30 nM. Phosphoinositide 3-kinase γ (PI3Kγ) is expressed primarily in hematopoietic cells and plays several important roles in immunity. CAY10505 also prevents other α, β, and δ isoforms with IC50 of 0.94, 20, and 20 μM, respectively. CAY10505 significantly inhibits only the unrelated casein kinase 2 (CK2, IC50 = 20 nM). CAY10505 also suppress the phosphorylation of the PI3K substrate PKB/Akt in murine macrophages (IC50 = 228 nM). Oral administration of CAY10505 decreases neutrophil recruitment in mice to an extent that is comparable to that observed in PI3Kγ-deficient mice. [1]
Reference
1H-Benzimidazole,1-[4-chloro-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-
475111-38-7
PHA-665752
477575-56-7
BAG956/NVP-BAG956
853910-02-8
GSK2126458
1086062-66-9